Atlas Trials

Oral Bio-equivalence Study

Clinical trial NCT05145621 · COMPLETED

Trial details

NCT number
NCT05145621
Sponsor
Alembic Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
BioequivalenceSafety
Start date
2015-10-29
Primary completion
2016-01-15
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.